We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celoxica | LSE:CXA | London | Ordinary Share | GB00B0L9TZ33 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.20 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 9102D Celoxica Holdings PLC 22 September 2008 Celoxica announces collaboration with Intel on PCI Express® Technology Celoxica to provide low-latency market data for Intel® platforms at HPC on Wall Street, 22nd September 2008 22nd September - Celoxica Holdings plc (AIM: CXA) a leading provider of low latency trading solutions, announces today that as a result of customer demand for Celoxica's hardware-accelerated market data products on the latest server platforms it is working with Intel to produce a PCI Express® implementation of its Accelerator Series. This collaboration will see Celoxica's acceleration technology implemented in the Intel fasterLAB facility, which targets simulation of FSI and HPC workloads. The new platform has a high-speed 8-lane PCI Express interface to the latest generation of Xilinx FPGAs with 4 Gigabit Ethernet SFPs, either copper or fiber, connected directly to the FPGA to give the lowest-latency acceleration of financial protocol handling. The Celoxica Accelerator for PCI Express will be available on Intel® platforms from October 2008, with the first supported high volume feeds being OPRA, ISE, NASDAQ ITCH, CME, ICE, NYSE Arca and Eurex. Recent tests for the Accelerator have proven latency of less than 10 microseconds, processing market data from ISE, OPRA and ITCH at over 3 million messages per second. A further seven feeds will be available in Q1 2009. Lee Staines, CEO of Celoxica commented: 'Our collaboration with Intel has been strengthened since the Celoxica re-launch into financial services at the beginning of the year. A shared vision of providing ultra low latency solutions, on the latest technology available, whilst ensuring openness of the underlying architecture has helped enable the partnership we share today. Furthermore, by working with Intel and with the client feedback from our early adopter programs, we have been able to ensure the product roadmap would provide scale for our line handler solution without sacrificing speed, consistency or reliability.' Nigel Woodward, Director Financial Services at Intel comments: "Intel continually looks to align its technology with partner capabilities which make the combination relevant to today's market demands. The area of market data is at the forefront of the latency drive, plus the need to integrate with core applications in the trading, risk and compliance space of the front office. This calls for a collaborative approach to technology in order to test the appropriate combinations in the infrastructure. We have been impressed with the pro activity of Celoxica to show interoperability with Intel - and look forward to solution based results." Intel fasterLAB is the engineering capability applied to the focus on FSI. Centered on the facilities in London UK, the lab gives access to Intel engineering and technology plus major investments by partnering companies to enable simulation and measurement of FSI workloads - from infrastructure, risk, trading, market data and latency measurement. fasterLAB has access to Intel's worldwide lab and engineering resource and is available to clients and partners. ENQUIRIES Celoxica Holdings plc (www.celoxica.com) Tel. +44 (0)1235 863 656 Lee Staines, CEO ICIS Tel. +44 (0) 20 7651 8688 Tom Moriarty +44 (0) 7843 260 623 Caroline Evans-Jones Arbuthnot Tel. +44 (0) 20 7012 2000 Tom Griffiths Alasdair Younie About Celoxica www.celoxica.com Celoxica is a leader in accelerated computing solutions, with a focus on low latency, high volume market data feed processing for financial services. Headquartered in Abingdon, Oxfordshire and New York, Celoxica is a public company quoted on AIM at the London Stock Exchange (AIM: CXA). Celoxica's solutions combine accelerated computing technology (hardware, firmware, software and APIs) with professional services to enable ultra low latency, high throughput processing capabilities to traders in today's automated and electronic trading environments.
1 Year Celoxica Chart |
1 Month Celoxica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions